Bone Cement & Glue Market Outlook 2022-2032: Growth Trends & Key Players - Zimmer Biomet, Stryker, Arthrex, Smith & Nephew

The global bone cement & glue market is projected to expand steadily, rising from a valuation of approximately US $ 1.3 billion in 2022 to US $ 2.2 billion by the end of 2032, growing at a CAGR of 5.4 % over the period.

Browse Full Report: https://www.factmr.com/report/bone-cement-and-glue-market

Types: Bone Cement vs Bone Glue

Bone Cement-including polymethyl methacrylate (PMMA), calcium phosphate, and glass polyalkenoate varieties, both antibiotic‐loaded and non‐loaded-holds nearly 60% of the global market share, driven by its extensive use in arthroplasty and trauma surgeries.

Bone Glue-encompassing synthetic and natural formulations-is gaining traction as an adjunct or substitute in fracture repair and minimally invasive procedures. Its demand is increasingly driven by innovations and expanding surgical adoption.

Application: Arthroplasty Dominates

Among applications, arthroplasty leads the market, with growing volumes of knee, hip, and shoulder replacements worldwide. Meanwhile, kyphoplasty and vertebroplasty are also rising in popularity as minimally invasive interventions for vertebral fractures, particularly in the geriatric population.

End‐User Segments: Hospitals Lead

Among end‐users, hospitals represent the largest share, benefiting from established infrastructure, high volume of orthopedic and trauma procedures, and adoption of advanced cement and glue products. Ambulatory surgery centers (ASCs) follow closely, especially in the U.S., while clinics play a supplementary role.

Regional Landscape

North America leads the global market due to well-developed healthcare infrastructure, high incidence of orthopedic conditions, and strong patient awareness. Europe follows, with Germany and France holding key positions.

The Asia‐Pacific region is the fastest-growing market, driven by rising healthcare spending, medical tourism, and expanding geriatric demographics-particularly in China and India, where growth rates outpace global averages.

Buy Report - Instant Access: https://www.factmr.com/checkout/7792

Recent Market Developments & Competitive Landscape

Strong Market Drivers & Innovation

The market is fueled by growing prevalence of osteoporosis, rising traffic accidents and sports injuries, and escalating demand for joint replacement and spinal surgeries globally. Regulatory support, reimbursement improvements, and technological advances in formulations-such as antibiotic‐loaded PMMA cements, bioactive adhesives, and self-setting or bioresorbable glues-have expanded clinical applicability and adoption in both developed and emerging regions.

Key Players and Competitive Strategies

Major companies dominating the landscape include Stryker, Zimmer Biomet, Smith & Nephew, Arthrex, Exactech, Teknimed, CryoLife, Heraeus Medical, Cardinal Health, DJO Global, and Trimph.

Zimmer Biomet recently launched Tekcem 1G and Tekcem 3G antibiotic bone cements in India, catering to prosthesis fixation in arthroplasty and revision surgeries-a clear move to strengthen its regional footprint and product portfolio in a fast‐growing market.

Arthrex has established a strategic distribution agreement with Celularity to commercialize placenta‐derived biomaterials in the U.S.-enhancing its offerings in orthopedics and sports medicine.

Smaller innovators such as BioMed Elements are emerging, providing customizable biomaterials and novel formulations (e.g., biopolymers, orthobiologics) for niche surgical applications.

These companies engage in regulatory approvals, product launches, hospital partnerships, and global expansion to remain competitive and consolidate their positions.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7792

Market Outlook: Growth Trajectory & Strategic Implications

Forecast & Trends

Over 2022-2032, the bone cement & glue market is expected to grow at a 5.4% CAGR, with bone cement remaining dominant (around 60% share) thanks to its widespread use in arthroplasty, while demand for bone glue accelerates due to minimally invasive surgery trends.

Regional growth is expected to be most rapid in Asia‐Pacific, with China and India poised to become major volume drivers; North America and Europe will remain key revenue contributors due to mature infrastructure and high procedure volumes.

Strategic Considerations

Product innovation is essential: Antibiotic‐loaded, high‐viscosity PMMA cements; biodegradable or faster curing glue formulations can offer clinical advantages and differentiate offerings.

Geographic expansion: Targeting high-growth markets like India and China should be paired with regulatory engagement and local partnerships.

Collaboration & alliances: Partnerships like Arthrex-Celularity and Zimmer's Tekcem launch demonstrate the value of jointly developing and distributing next‐generation orthobiologics.
End-user alignment: Focusing on hospital systems and ASC networks, especially in orthopedics, can help drive uptake of advanced cement and glue products.

Check out More Related Studies Published by Fact.MR Research:

Ethyl Mercaptan Market: https://www.factmr.com/report/ethyl-mercaptan-market

Automotive Window Seals Market: https://www.factmr.com/report/automotive-window-seals-market

High Current Springs Market: https://www.factmr.com/report/high-current-springs-market

Liner regulators Market: https://www.factmr.com/report/liner-regulators-market

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team : sales@factmr.com

About Us:

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

This release was published on openPR.